|Articles|August 18, 2022
An Innovative Excipient-Enhanced Growth Formulation for Treatment of Lung Cancer
Author(s)Lonza
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
PharmTech Weekly News Roundup – Week of December 1, 2025
2
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
3
BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation
4
FDA Deploys Agentic AI Capabilities for Agency Staff
5
